Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Buy
64
SGHT Quote, Financials, Valuation and Earnings
Last price:
$3.62
Seasonality move
:
-3.68%
Day range:
$3.20 - $3.50
52-week range:
$2.03 - $8.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.23x
P/B ratio:
2.29x
Volume:
184.7K
Avg. volume:
173.8K
1-year change:
-38.24%
Market cap:
$177.9M
Revenue:
$79.9M
EPS (TTM):
-$0.98
Analysts' Opinion
-
Consensus RatingSight Sciences has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.68, Sight Sciences has an estimated upside of 7.07% from its current price of $3.44.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $3.44.
Fair Value
-
According to the consensus of 8 analysts, Sight Sciences has 7.07% upside to fair value with a price target of $3.68 per share.
SGHT vs. S&P 500
-
Over the past 5 trading days, Sight Sciences has overperformed the S&P 500 by 3.79% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Sight Sciences does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sight Sciences revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sight Sciences reported revenues of $17.5M.
Earnings Growth
-
Sight Sciences has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Sight Sciences reported earnings per share of -$0.28.
Enterprise value:
108.7M
EV / Invested capital:
0.93x
Price / LTM sales:
2.23x
EV / EBIT:
--
EV / Revenue:
1.39x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$66.9M
Return On Assets:
-34.24%
Net Income Margin (TTM):
-63.24%
Return On Equity:
-52.44%
Return On Invested Capital:
-37.91%
Operating Margin:
-79.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $75.3M | $81.5M | $78.1M | $19.3M | $17.5M | |
| Gross Profit | $62.9M | $69.9M | $66.9M | $16.5M | $15.1M | |
| Operating Income | -$79.3M | -$54.4M | -$49.7M | -$14.7M | -$13.9M | |
| EBITDA | -$74.6M | -$48.6M | -$43.7M | -$14.9M | -$12.7M | |
| Diluted EPS | -$1.66 | -$1.12 | -$0.98 | -$0.33 | -$0.28 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.5M | $255.3M | $193.7M | $152.1M | $126.9M | |
| Total Assets | $60.5M | $258.6M | $196.6M | $155.6M | $129.7M | |
| Current Liabilities | $9.3M | $12M | $15.1M | $11.7M | $12.1M | |
| Total Liabilities | $161.3M | $46.7M | $50.3M | $46.4M | $52.1M | |
| Total Equity | -$100.8M | $211.9M | $146.4M | $109.2M | $77.6M | |
| Total Debt | $32.1M | $32.8M | $33.5M | $33.7M | $39.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$71.4M | -$39.6M | -$24.2M | -$9.8M | -$11.6M | |
| Cash From Investing | -$869K | -$782K | -$268K | -$117K | -- | |
| Cash From Financing | $1M | $318K | $5.9M | -$942K | $16K | |
| Free Cash Flow | -$72.3M | -$40.4M | -$24.2M | -$9.9M | -$11.6M | |
SGHT
Sector
Market Cap
$177.9M
$34.7M
Price % of 52-Week High
40.71%
42.33%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.66%
1-Year Price Total Return
-38.24%
-41.18%
Beta (5-Year)
--
0.653
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.33
200-day SMA
Sell
Level
$4.06
Bollinger Bands (100)
Buy
Level
2.5 - 3.2
Chaikin Money Flow
Sell
Level
-868.3K
20-day SMA
Buy
Level
$3.18
Relative Strength Index (RSI14)
Buy
Level
60.84
ADX Line
Buy
Level
26.73
Williams %R
Neutral
Level
-25
50-day SMA
Buy
Level
$2.87
MACD (12, 26)
Buy
Level
0.14
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-2.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.8564)
Sell
CA Score
(Annual)
Level (-0.8345)
Buy
Beneish M-Score
(Annual)
Level (-3.8554)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.0417)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Stock Forecast FAQ
In the current month, SGHT has received 2 Buy ratings 6 Hold ratings, and 0 Sell ratings. The SGHT average analyst price target in the past 3 months is $3.68.
-
Where Will Sight Sciences Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sight Sciences share price will rise to $3.68 per share over the next 12 months.
-
What Do Analysts Say About Sight Sciences?
Analysts are divided on their view about Sight Sciences share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sight Sciences is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Sight Sciences's Price Target?
The price target for Sight Sciences over the next 1-year time period is forecast to be $3.68 according to 8 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is SGHT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sight Sciences is a Hold. 6 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SGHT?
You can purchase shares of Sight Sciences via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sight Sciences shares.
-
What Is The Sight Sciences Share Price Today?
Sight Sciences was last trading at $3.62 per share. This represents the most recent stock quote for Sight Sciences. Yesterday, Sight Sciences closed at $3.44 per share.
-
How To Buy Sight Sciences Stock Online?
In order to purchase Sight Sciences stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
